Tilray Brands Reports Fiscal 2025 Net Revenue of $821 Million, Canadian Cannabis Leads by Revenue, International Cannabis Sales Surge 71% in Q4

Reuters
07-29
Tilray Brands Reports Fiscal 2025 Net Revenue of $821 Million, Canadian Cannabis Leads by Revenue, International Cannabis Sales Surge 71% in Q4

Tilray Brands Inc. has announced its financial results for the fourth quarter and fiscal year ending May 31, 2025. The company reported a fiscal year net revenue of $821 million, with a constant currency figure of $834 million. Strategic decisions impacted revenue by $35 million during this period. The fourth quarter saw international cannabis revenue surge by 71%, and there was a 19% increase for the fiscal year. In Canada, the company maintained its leading position by revenue in the cannabis sector. Globally, the cannabis gross margin increased by approximately 700 basis points over the fiscal year. Tilray's beverage segment experienced a 19% revenue growth, reaching $241 million for the fiscal year, while the wellness segment grew by 9%, totaling $60 million. The company boasts a strong balance sheet with $256 million available in cash and marketable securities, alongside total debt repayments amounting to roughly $100 million to date. Looking ahead, Tilray Brands expects its adjusted EBITDA for fiscal year 2026 to range between $62 million and $72 million. The company plans to enhance its global supply chain and expand its cultivation footprint to meet growing demand in both Canadian and international markets.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tilray Brands Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9501732-en) on July 28, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10